Indaba Capital Management, L.P. Quant / Systematic

Location: San Francisco, CA

CIK: 0001524362 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value: $234M (51.1% shares, 48.9% debt)

Holdings (9)

— EQUITY COMWLTH 40.0%

Value $93.53M Shares 4,700,000 Est. Cost $19.61 Unrealized —

— ESPERION THERAPEUTICS INC NE 13.7%

Value $32.02M Shares 33,750,000 Est. Cost $0.95 Unrealized —

— BANDWIDTH INC 13.4%

Value $31.41M Shares 40,250,000 Est. Cost $0.62 Unrealized —

ONTF ON24 INC 11.1%

Value $25.95M Shares 4,240,256 Est. Cost $22.91 Unrealized -73.0%

— XOMETRY INC 7.9%

Value $18.55M Shares 21,750,000 Est. Cost $0.77 Unrealized —

— ACCELERATE DIAGNOSTICS INC 5.3%

Value $12.41M Shares 24,083,901 Est. Cost $0.64 Unrealized —

— IRONWOOD PHARMACEUTICALS INC 3.4%

Value $7.961M Shares 9,000,000 Est. Cost $0.88 Unrealized —

— STANDARD BIOTOOLS INC 3.3%

Value $7.632M Shares 7,660,000 Est. Cost $1.00 Unrealized —

— SUMMIT HOTEL PPTYS 1.8%

Value $4.248M Shares 4,500,000 Est. Cost $0.94 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	EQUITY COMWLTH	4,700,000	$93.53M	40.0%	$19.61	—	COM SH BEN INT	294628102
—	ESPERION THERAPEUTICS INC NE	33,750,000	$32.02M	13.7%	$0.95	—	NOTE 4.000%11/1	29664WAB1
—	BANDWIDTH INC	40,250,000	$31.41M	13.4%	$0.62	—	NOTE 0.500% 4/0	05988JAD5
ONTF	ON24 INC	4,240,256	$25.95M	11.1%	$22.91	-73.0%	COM	68339B104
—	XOMETRY INC	21,750,000	$18.55M	7.9%	$0.77	—	NOTE 1.000% 2/0	98423FAB5
—	ACCELERATE DIAGNOSTICS INC	24,083,901	$12.41M	5.3%	$0.64	—	NOTE 5.000%12/1	00430HAC6
—	IRONWOOD PHARMACEUTICALS INC	9,000,000	$7.961M	3.4%	$0.88	—	NOTE 1.500% 6/1	46333XAH1
—	STANDARD BIOTOOLS INC	7,660,000	$7.632M	3.3%	$1.00	—	NOTE 5.250%12/0	34385PAF5
—	SUMMIT HOTEL PPTYS	4,500,000	$4.248M	1.8%	$0.94	—	NOTE 1.500% 2/1	866082AA8